Company Quick10K Filing
Arcadia Biosciences
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-25
S-1 2019-12-11 Public Filing
10-Q 2019-09-30 Filed 2019-11-06
S-1 2019-07-26 Public Filing
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-04-01
S-1 2018-12-27 Public Filing
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-20
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-08
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-08
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-06-25
8-K 2020-11-12
8-K 2020-11-12
8-K 2020-08-13
8-K 2020-07-06
8-K 2020-07-06
8-K 2020-06-26
8-K 2020-06-01
8-K 2020-05-14
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-04-16
8-K 2020-03-25
8-K 2019-11-06
8-K 2019-09-27
8-K 2019-09-11
8-K 2019-09-05
8-K 2019-08-22
8-K 2019-08-14
8-K 2019-08-05
8-K 2019-06-12
8-K 2019-06-03
8-K 2019-05-20
8-K 2019-05-08
8-K 2019-03-27
8-K 2019-02-28
8-K 2019-02-13
8-K 2018-11-07
8-K 2018-08-08
8-K 2018-07-31
8-K 2018-06-11
8-K 2018-06-06
8-K 2018-05-12
8-K 2018-05-09
8-K 2018-05-07
8-K 2018-05-02
8-K 2018-03-20
8-K 2018-03-19
8-K 2018-01-19

Arcadia Biosciences Financials

RKDA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash11,27880,00362,96623,97329,54027,36010,4732,0137,55913,4382,9309,12520,4189,6676,66911,99810,43814,64620,541
Accounts Receivable15014568570658717797349284432731,2315218019316579125127
Inventory5215725982943163063602522422862362293092823541811878391,843
PP&E6636335975,2446566365805,4494864173695,1802802702655,1964606391,283
Assets19,42084,98879,97374,24270,10565,70961,58656,57452,64848,43318,97816,57022,59931,13227,21724,02421,95025,34637,302
Accounts Payable424222366285
Long-Term Debt9,67019,34919,46224,93024,97825,02725,07725,12725,17525,22500000113
Liabilities38,77537,06236,14034,01734,62834,42134,07534,37634,27733,6728,3118,56321,93223,00214,29511,20921,31717,06023,069
Stockholders' Equity-91,87547,92643,83340,22535,47731,28827,51122,19818,37114,76110,6678,0076678,13012,92212,8156338,28613,544
Income Statement ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8151,4301,8231,3468527211,075-691,01899158932214436370158203392
Cost of Revenue
Gross Profit
R&D1,8322,0863,1791,8692,2022,2162,2551,9901,8231,6691,7492,1661,3961,7941,3341,5051,9501,931
SG&A2,6382,7852,8182,8783,4362,7592,6873,3683,0522,9432,4152,2412,6212,9493,0112,8123,1454,477
Tax22990-97-1966117110813024115190-3
Net Income-5,803-3,677-4,619-3,857-5,190-4,551-4,175-5,708-4,216-4,006-4,525-2,960-10,615-6,6694,450-12,6124,238-14,187
Cash Flow ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-2,598-3,984-4,581-3,946-4,855-3,992-3,931-4,277-4,530-4,387-2,365-2,683-2,617-4,018-3,969-4,460-3,757
Cash Investing-7-16-11,347-34,99010,3281,679-13,111-4,19710,06010,26617,9748,8783,8761,0672,4221,790-5,497
Cash Financing-2,68872,725-1,109-579413315514160-26,117010,034-47-136,87815,149